MedPath

A CLINICAL STUDY AMONG PATIENTS OF PRIMARY CUTANEOUS AMYLOIDOSIS REGARDING DISEASE SYMPTOMS AND ITS CAUSES USING SKIN BIOPSY RESULTS AND DERMOSCOPY

Not Applicable
Conditions
Health Condition 1: E854- Organ-limited amyloidosis
Registration Number
CTRI/2022/11/047739
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of both sexes (males and females), aged >18 years,

2.Patients who have clinical diagnosis of PCA.

3.Patients who have not taken any form of treatment for PCA.

4.Patients who are willing to sign the written consent form before participating in the study.

Exclusion Criteria

1.Patients with systemic amyloidosis.

2.Patients who had taken any form of treatment for the disease.

3.Pregnant or lactating women or immunocompromised patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath